文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

外科脓毒症按感染部位的表型异质性:一项前瞻性纵向研究

Phenotypic heterogeneity by site of infection in surgical sepsis: a prospective longitudinal study.
PubMed 文献 · Crit Care · 2020-05-07
一句话结论外科脓毒症按感染部位呈现不同宿主反应和长期结局,腹部和肺部感染长期结局差,皮肤软组织和泌尿系感染较好,血管感染最差。

该前瞻性纵向研究纳入316例外科脓毒症患者,按感染部位分为腹部(44%)、肺部(19%)、皮肤软组织(17%)、泌尿生殖(12%)和血管(7%)五组,评估基线易感性、打击特征、系列生物标志物、住院和长期结局。腹部感染多入院时存在且需 source control,长期结局差(37% CCI,49% poor discharge dispositions,30% 1年死亡率);肺部感染多为医院获得性肺炎,长期结局同样差(54% CCI,47% poor disposition,32% 1年死亡率);皮肤软组织和泌尿系感染患者较年轻、合并症少、免疫紊乱轻、器官功能障碍恢复快,长期结局较好(皮肤软组织 23% CCI,39% poor disposition,13% 1年死亡率;泌尿系 10% CCI,20% poor disposition,10% 1年死亡率);血管感染患者为老年男性、合并症多、促炎反应减弱、器官功能障碍持续,长期结局最差(38% CCI,67% poor disposition,57% 1年死亡率)。结论认为外科脓毒症按感染部位在基线易感性、宿主反应和临床结局方面存在显著差异。

要点

  • 腹部感染占44%,多入院时存在且需 source control,长期结局差:37% CCI,49% poor discharge dispositions,30% 1年死亡率。
  • 肺部感染占19%,多为医院获得性肺炎,长期结局差:54% CCI,47% poor disposition,32% 1年死亡率。
  • 皮肤软组织感染占17%,长期结局较好:23% CCI,39% poor disposition,13% 1年死亡率。
  • 泌尿生殖感染占12%,长期结局最好:10% CCI,20% poor disposition,10% 1年死亡率。
  • 血管感染占7%,长期结局最差:38% CCI,67% poor disposition,57% 1年死亡率。

适用人群与场景

  • 316例外科脓毒症患者,以白人为主,半数男性,平均年龄62岁,合并症负担高,30天死亡率低(10%)。

诊断标准与关键阈值

  • CCI定义为在ICU停留>14天并伴有器官功能障碍。

研究设计与关键结果

  • 研究为纵向研究,纳入316例外科脓毒症患者,按感染部位分为腹部(44%)、肺部(19%)、皮肤软组织(17%)、泌尿生殖(12%)和血管(7%)五组。
  • 腹部感染多入院时存在且需 source control,促炎反应和免疫抑制更持久,器官功能障碍持续,长期结局差:37% CCI,49% poor discharge dispositions,30% 1年死亡率。
  • 肺部感染多为医院获得性肺炎,促炎反应和器官功能障碍持续时间相似,但免疫抑制正常化,长期结局同样差:54% CCI,47% poor disposition,32% 1年死亡率。
  • 皮肤软组织和泌尿生殖感染患者较年轻、合并症较少、免疫反应紊乱较轻、器官功能障碍恢复更快;皮肤软组织长期结局较好(23% CCI,39% poor disposition,13% 1年死亡率),泌尿生殖最好(10% CCI,20% poor disposition,10% 1年死亡率)。
  • 血管感染患者为老年男性、合并症更多,促炎反应减弱、基线免疫抑制和器官功能障碍持续,长期结局最差:38% CCI,67% poor disposition,57% 1年死亡率。

证据类型、等级与局限

  • 证据类型:前瞻性纵向研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,外科脓毒症按感染部位在基线易感性、宿主反应和临床结局方面存在显著差异,既往研究聚焦住院死亡率差异,本研究提供了不同感染部位宿主反应和长期结局的独特见解。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The role of site of infection in sepsis has been poorly characterized. Additionally, sepsis epidemiology has evolved. Early mortality has decreased, but many survivors now progress into chronic critical illness (CCI). This study sought to determine if there were significant differences in the host response and current epidemiology of surgical sepsis categorized by site of infection.

STUDY DESIGN: This is a longitudinal study of surgical sepsis patients characterized by baseline predisposition, insult characteristics, serial biomarkers, hospital outcomes, and long-term outcomes. Patients were categorized into five anatomic sites of infection.

RESULTS: The 316 study patients were predominantly Caucasian; half were male, with a mean age of 62 years, high comorbidity burden, and low 30-day mortality (10%). The primary sites were abdominal (44%), pulmonary (19%), skin/soft tissue (S/ST, 17%), genitourinary (GU, 12%), and vascular (7%). Most abdominal infections were present on admission and required source control. Comparatively, they had more prolonged proinflammation, immunosuppression, and persistent organ dysfunction. Their long-term outcome was poor with 37% CCI (defined as > 14 in ICU with organ dysfunction), 49% poor discharge dispositions, and 30% 1-year mortality. Most pulmonary infections were hospital-acquired pneumonia. They had similar protracted proinflammation and organ dysfunction, but immunosuppression normalized. Long-term outcomes are similarly poor (54% CCI, 47% poor disposition, 32% 1-year mortality). S/ST and GU infections occurred in younger patients with fewer comorbidities, less perturbed immune responses, and faster resolution of organ dysfunction. Comparatively, S/ST had better long-term outcomes (23% CCI, 39% poor disposition, 13% 1-year mortality) and GU had the best (10% CCI, 20% poor disposition, 10% 1-year mortality). Vascular sepsis patients were older males, with more comorbidities. Proinflammation was blunted with baseline immunosuppression and organ dysfunction that persisted. They had the worst long-term outcomes (38% CCI, 67% poor disposition, 57% 1-year mortality).

CONCLUSION: There are notable differences in baseline predisposition, host responses, and clinical outcomes by site of infection in surgical sepsis. While previous studies have focused on differences in hospital mortality, this study provides unique insights into the host response and long-term outcomes associated with different sites of infection.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Stortz JA, Cox MC, Hawkins RB, et al. Phenotypic heterogeneity by site of infection in surgical sepsis: a prospective longitudinal study. Crit Care. 2020. PMID: 32381107. doi:10.1186/s13054-020-02917-3

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。